Molecular characterization of Plasmid-Mediated Non-O157 VerotoxigenicEscherichia coliIsolatedfromInfants and children with diarrhea by Md Fazlul, Karim Khan et al.
Open Access     Baghdad Science Journal                                P-ISSN: 2078-8665 
2020, 17(3):710-719                                                            E-ISSN: 2411-7986 
 
710 
DOI: http://dx.doi.org/10.21123/bsj.2020.17.3 0710 
 
Molecular Characterization of Plasmid-Mediated Non-O157 Verotoxigenic 
Escherichia coli Isolated from Infants and Children with Diarrhea 
 
Md Fazlul Karim Khan
1
   Shah Samiur Rashid
1
*   Mohammad Nazmul 
2
 
Hassan Maziz
3
   Aizi Nor Mazila Ramli
1
   Roesnita Baharuddin
4 
 
1
Faculty of Industrial Sciences Technology, Universiti Malaysia Pahang, Gambang, 26300 Pahang, Malaysia 
2
Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang (UMP,),Gambang, 26300 Pahang 
Malaysia, 
3
Graduate School of Medicine, Perdana University, Jalan MAEPS Perdana, Serdang, 43400 Selangor, Malaysia 
4
Department of Pathology, Hospital Tengku Ampuan Afzan, 25100 Kuantan, Pahang, Malaysia 
*
Corresponding author: 
*
samiur@ump.edu.my  
*
ORCID ID: 
*
https://orcid.org/0000-0003-1109-5706 
 
Received 30/8/2019,  Accepted 16/2/2020,  Published 1/9/2020 
 This work is licensed under a Creative Commons Attribution 4.0 International License. 
 
              
Abstract:  
A significant increase in the incidence of non-O157 verotoxigenic Escherichia coli (VTEC) 
infections have become a serious health issues, and this situation is worsening due to the dissemination of 
plasmid mediated multidrug-resistant microorganisms worldwide. This study aims to investigate the 
presence of plasmid-mediated verotoxin gene in non-O157 E. coli. Standard microbiological techniques 
identified a total of 137 E. coli isolates. The plasmid was detected by Perfectprep Plasmid Mini preparation 
kit. These isolates were subjected to disk diffusion assay, and plasmid curing with ethidium bromide 
treatment. The plasmid containing isolates were subjected to a polymerase chain reaction (PCR) for 
investigating the presence of plasmid mediated verotoxin gene (VT1 and VT2) in non-O157 E. coli. Among 
the 137 E. coli isolates, 49 isolates were non-O157 E. coli while 29 (59.1%) isolates were verotoxin 
producing non-O157 serotypes and 26 non-O157 VTEC isolates possessed plasmids. Certain isolates 
harboured single sized plasmid while others had multiple plasmids with different size varied from 1.8kb to 
7.6kb. A plasmid containing all (100%) the isolates was multidrug-resistant. Eight isolates changed their 
susceptibility patterns while three isolates were found to lose plasmid after post plasmid curing treatment and 
the rest of the isolates (15) remained constant. Different PCR sets characterized 3 plasmid-mediated 
verotoxins producing non-O157 E. coli. This current study demonstrated the occurrence of plasmid mediated 
verotoxin gene in non-O157 E. coli. To the best of our knowledge, this is the first report in the global 
literature on plasmid-mediated verotoxin gene in non-O157 E. coli. Timely diagnosis and surveillance of 
VTEC infections should prioritize to stop or slow down the virulence gene for dissemination by plasmid-
mediated gene transfer amongst the same bacteria or other species. 
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Introduction: 
In recent times, the exhibition of multidrug-
resistance by bacteria has continued to establish a 
significant public health problem that is yet to be 
overcome. The occurrence, spread, and persistence 
of antibiotic resistance in bacteria by various 
contributory factors are poorly understood (1). 
Escherichia coli (E. coli) was listed to be a cause of 
serious infection in a community setting (2) and 
Shiga toxin-producing E. coli (STEC) known as 
verotoxin-producing E. coli (VTEC) has emerged as 
a pathogen that causes numerous risk to public 
health (3). VTEC, virulent groups of bacteria allied 
with mild diarrhea to severe bloody diarrhea among 
the children and infants (4). O157: H7 VTEC 
serotype associated with human outbreaks and non-
O157 VTEC serotypes has been identified for 
several human illnesses (5). In general, the most 
outbreaks of human infections by VTEC occur 
through the ingestion of contaminated foods or 
water, vegetables, fruits, undercooked meats, 
unpasteurized milk, and dairy products. Direct 
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animal contacts or environmental factors can also 
cause infections (2). 
 Currently, among the numerous 
environmental and genetic factors; plasmid has 
carried the resistant properties against multiple 
drugs in bacteria while different resistance 
genes transfer to a sensitive counterpart (6). 
Plasmids play an essential role in disseminating 
bacterial resistant properties among the same or 
different clinical pathogens by conjugation (7). 
These conjugative plasmids are indeed spread 
antibiotic resistance in bacterial families; 
Enterobacteriaceae, and Enterococcaceae (8). This 
resistance to antibiotics occurs in bacteria through 
chromosomal mutation and acquiring genetic 
materials by plasmids. Generally, plasmid-
bacterium creates superbugs and disperse in clinical 
settings, especially in nosocomial pathogens (9). A 
wide range of plasmids carrying multidrug-resistant 
(MDR) genes are easily transmissible to sensitive 
bacterial species and causes a major medical 
problem (10). Moreover, multiple plasmid-mediated 
resistance mechanisms have been increasing in 
many bacteria, thus resulting in diagnostic and 
therapeutic challenges. Also, such developed 
resistance can make sensitive pathogens resistant to 
multiple antibiotics. Consequently, the treatment of 
infections becomes more difficult and at times 
almost unmanageable. Therefore, antibiotics are 
essential to support therapy in modern medicine for 
the treatment of infectious diseases. However, 
widespread and misuse of antibiotics has spread 
resistant mechanisms towards different antibiotics 
(11-13). Besides, antibiotic susceptibility of 
bacterial strains is not constant, but vigorous and 
changes with period and environment (14). As a 
result, more people die from resistant infections 
every year. Unfortunately, the discovery, 
development of antibiotics, and inappropriate usage 
of antibiotics have led to the rapid existing of 
antibiotic-resistant isolates across the world. 
Understanding the molecular epidemiology of 
resistant plasmids have been complex due to 
diversity and dynamic characteristics. Meanwhile, 
identification of the infection sources could be a 
key-point step towards decreasing the prevalence of 
variants pathogen as well as reducing the risk, 
prevent, or treat infections. Consequently, it is 
essential to survey the prevalence of plasmid-
mediated genes in hospital settings, which might 
influence physicians to choose a broad-spectrum 
antimicrobial agent. This scenario provoked us to 
determine and characterize the verotoxin gene (VT) 
genes in non-O157 E. coli among young infants and 
children in Kuantan, Malaysia, and shed light on the 
phylogenetic similarity index, virulence gene 
profiles, and the sequence analysis. 
 
Materials and Methods: 
Samples types, sources and study sites  
In this study, 137 E. coli isolates were 
obtained from fecal samples. Isolates were assessed 
for the existence of virulence genes associated with 
diarrhea. These isolates were obtained from 
children below 5 years old at Tengku Ampuan 
Afzan Hospital, Kuantan, Malaysia, from 
September 2018 to April 2019. All the clinical 
isolates were plated on MacConkey agar (Oxoid, 
United Kingdom) and incubated at 37°C for 
24 hours under aerobic conditions. 
Plasmid isolation and profiling 
Perfectprep Plasmid Mini preparation kit 
(Eppendorf, Germany) was used to extract plasmid 
DNA according to the manufacturer’s instructions 
without any modification. After purification, the 
molecular weight of plasmid DNA was determined 
and compared with supercoiled DNA 2 to 10 kb 
ladder (Promega, USA) (15). Electrophoresis of the 
DNA was carried out at 80 volts on a 1.5% agarose 
gel for 60 minutes (16). 
Phylogenetic analysis based on antibiotic 
susceptibility 
 All the plasmid positive non-O157 VTEC 
isolates were subjected to susceptibility test by the 
disk diffusion antimicrobial assay of Kirby-Bauer 
(17) and the phylogenetic relatedness was generated 
using “unweighted pair group average (UPGMA) 
algorithms” of PAST. 
Plasmid Curing 
 A plasmid containing non-O157 VTEC 
strains were subjected to curing according to Zaman 
et al., (18) but with modifications. Ethidium 
bromide 125µg/ml was selected as a curing agent, 
cure plasmids successfully at a higher rate. 
Amoxicillin-resistant non-O157 VTEC isolates 
were used as selective marker and isolates 
containing plasmids were subjected to curing 
treatment.  Each of the organisms was overnight 
cultured in nutrient broth (NB) solution containing 
amoxicillin at 37°C aerobically and diluted to 10
4
 
cells/mL with freshly prepared nutrient broth by 
serial dilution methods and the optical density was 
checked using the spectrophotometer. From each of 
the diluted samples, 0.5 mL dilution was added to 
4.5 mL of nutrient broth containing 125µg/ml 
ethidium bromide to form the concentration of 10
3
 
cells/mL.  The resulting sample was then incubated 
aerobically at 37°C in an orbital shaker at 150rpm 
for 48hours. After incubation, the post 48 hour’s 
growth was diluted to 10
3
 cells/ml with normal 
saline and 1 ml of the dilution from each sample 
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isolate was plated on Mueller Hinton agar for 
overnight incubation at 37°C (18). 
Antibiotic susceptibility post plasmid curing 
After the post plasmid curing, the 
amoxicillin-susceptible, lactose-fermenting, and 
indole-positive colonies have lost their plasmid(s); 
These isolates were considered as cured (mutant) E. 
coli. All the cured strains were subjected to 
susceptibility test by the disk diffusion 
antimicrobial assay of Kirby-Bauer (17). Obtained 
cured colonies were spread out on Mueller Hinton 
agar plates containing Amoxicillin- AMX, 
Cefalexin -CEX, Imipenem-IPM, Ciprofloxacin-
CIP, Amikacin-   AMK, Aztreonam- ATM 
antibiotic disks. After the aerobic incubation at 
37°C for 24 hrs, the zone of inhibition was 
measured aerobically according to Clinical and 
Laboratory Standard Institute (CLSI) guidelines 
(19).  
Plasmid-mediated verotoxin gene 
Of the total isolates of non-O157 VTEC, 
the extracted plasmid was purified to determine the 
presence of VT genes. Gel purification was done at 
a lower concentration of 0.7% agarose gels at 80 
volts for 60 minutes. QIAquick Gel Extraction kit 
was used to isolate the DNA templates from agarose 
gel according to the manufacturer’s guidelines. 
These DNA templates were used for further studies. 
The presence of VT gene (VT1 and VT2) in non-
O157 E. coli were determined by the polymerase 
chain reaction (PCR) protocol using two different 
types of oligonucleotide primers (VT1: F- 5'-CAC 
CAG ACA ATG TAA CCG CTG-3'; R- 5'-CAG 
TTA ATG TGG TGG CGA AGG- 3' and VT2: F- 
5'-GCG TCA TCG TAT ACA CAG GAG C-3'; R- 
5'-ATC CTA TTC CCG GGA GTT TAC G-3') 
(20). During the thermocycling conditions; an initial 
denaturation step at 94°C for 3 min for one cycle 
was followed by 35 cycles of denaturation at 94°C 
for 1 min, annealing at 55°C for 1 min and 
extension at 72°C for 2 min and final extension 1 
cycle of 72°C for 10 min in an Eppendorf 
Mastercycler (Eppendorf AG, Hamburg, Germany). 
The amplified DNA products were separated by 
electrophoresis on a 1.5% agarose gel at 80 volts for 
60 minutes, stained with 0.5μg/ml GelRed 
(Biotium, USA) and examined for DNA under 
ultraviolet light using gel documentation system 
(Amersham Imager 680, USA). All the PCR 
products were purified by QIAquick PCR 
purification kit (QIAGEN, USA) according to the 
manufacturer’s guidelines and sent for sequencing 
at Apical Scientific Sdn Bhd Malaysia. Sequences 
were analyzed using the BLAST program for the 
nucleotide database and aligned with VT1 and VT2 
gene.  
Statistical analyses  
A significant level between different groups 
was defined by Excel add-in Megastat, version 10.1 
software (2007) using Chi-squared test and p-value 
(p ≤0.05) was considered significant. 
 
Results: 
Based on gel electrophoresis, non-O157 
VTEC strains showed the occurrence of multiple 
bands with varying size in DNA plasmid.  
 Among the 137 E. coli isolates, 49 isolates 
were non-O157 E. coli while 29 (59.1%) isolates 
were verotoxin producing non-O157 serotypes. Of 
the total 29 clinical isolates of non-O157 VTEC 
were investigated for plasmid profile analysis, 
twenty-six strains were found to possess plasmid 
bands, which corresponded to 89.6% of the total 
isolates. The number of plasmids varied, ranged 
from one to four plasmids among the 26 positive 
isolates. The maximum number of plasmid copies 
of 4 was recorded in 1 strain; E-HR21. The 
remaining isolates possessed plasmids with a 
different number of bands. Among the rest isolates, 
three plasmids band have been found in 11 strains; 
E-HR2, E-HR3, E-HR4, E-HR13, E-HR16, E-
HR17, E-HR20, E-HR22, E-HR23, E-HR24 and E-
HR25 while two plasmids were found in 7 strains; 
E-HR1, E-HR5, E-HR6, E-HR10, E-HR11, E-
HR15, and E-HR18. Seven strains; E-HR7, E-HR8, 
E-HR9, E-HR12, E-HR14, E-HR19, and E-HR26 
possessed only 1 plasmid band. The Figure below 
shows various plasmids with different molecular 
weight, ranging from 2.3kb to 6.5kb (Supercoiled 
DNA ladder; Fig. 1). 
 
Figure 1. Detection of plasmids among 26 of non-
O157 VTEC, M: DNA ladder, Lanes: from 1-10 
represent the amplified product. Lane M: 
standard DNA marker. Lane 1:E-HR21; Lane 
2:E-HR2; Lane 3:E-HR7; Lane 4:E-HR13; Lane 
5:E-HR15; Lane 6:E-HR19; Lane 7:E-HR18; 
Lane 8:E-HR10; Lane 9:E-HR22; Lane 10:E-
HR26. 
 
 Among the twenty-six (89.6%) plasmid 
positive non-O157 VTEC isolates, 19 isolates 
possessed plasmids at 3-5years old children while 2 
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isolates at 0-1 years old. The occurrence of plasmid 
producing non-O157 VTEC was significant (p<0.05) 
among risk factors (age and number of total isolates) 
distributions ≤ 5 years old children associated with 
diarrhea (Table 1). 
 
Table 1. Plasmid profile analysis by source of 
isolations. 
Source of 
isolation by 
age (years) 
No. of non-
O157 VTEC 
isolates 
Plasmid (+) 
ve isolates 
p-
value  
0-1 2 2  
 
0.03 
1-2 1 1 
2-3 7 5 
3-4 11 11 
4-5 8 7 
Total  29 26 (89.6%) 
 
 
Figure 2. Phylogenetic relatedness among the 
plasmid positive isolates. 
 
 The phylogenetic dendrogram relatedness 
of 26 non-O157 VTEC isolates was based on the 
susceptibility of the isolates to antimicrobial agents. 
Clustering by UPGMA algorithm showed that three 
clades consistent with similarity coefficients were 
based on Bray-curtis similarity index. The highest 
prevalence rate (50%) of resistant E. coli were 
distributed in clade 2 followed by 26% in clade 1 
and 12% in clade 3, respectively. The remaining 
3(12%) isolates were not in the main clades (E-
HR13, E-HR18, E-HR10) (Fig. 2). Among the 
plasmid producing VTEC isolates, it is worth noting 
that E-HR10 exhibited 100% resistance to the tested 
antibiotics while E-HR9, E-HR17 and E-HR24 
were 84% followed by E-HR1, E-HR6, E-HR14 
and E-HR 26 (80%). The least resistance was 
recorded by E-HR3, E-HR11 and E-HR18 (57%) 
(Fig. 3).  
Amikacin (30 μg)-AMK, Imipenem 
(10 μg)-IPM, Ciprofloxacin- CIP, Aztreonam 
(30 μg)-ATM, Amoxicillin (25 μg)-AMX, Cefalexin 
(30 μg)-CEX. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Antibiotic susceptibility patterns of a plasmid containing non-O157 VTEC. 
 
The plasmid number and size varied 
significantly in 26 non-O157 VTEC isolates. The 
summary of antibiotic resistance screening tests and 
antibiogram profiles are presented in Table 2. The 
results exhibited that all (100%) of the twenty-six-
plasmid containing non-O157 VTEC isolates were 
multidrug-resistant and harboured plasmids, size 
between1.8kb, and 7.6kb. The highest number of 
bands was seen in E-HR21 isolate harboured 4 
plasmids ranging 1.8kb to 6.6kb. The remaining 
isolates had plasmids with different number of 
bands. Although all these isolates were multidrug-
0
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resistant, yet resistance patterns were not the same 
in all cases i.e., variation occurs in antimicrobial 
resistant patterns. The resistance level, among all 
the isolates, ranged from four drugs resistance to 
ten-drug resistance. Interestingly, only three (E-
HR7, E-HR19 and E-HR26) were resistant to 10 
different types of antibiotics (Table 2). 
 
Table 2. Multidrug-resistant of non-O157 VTEC isolates. 
Non-O157 
VTEC 
Resistance patterns 
No. of Plasmid 
bands 
Plasmid size 
(kb) 
E-HR1 AMX, CEX, CIP, MEM 2 5, 3.4 
E-HR2 AMX, CEX, CTX, MEM, IMP, AMK 3 6.6, 5, 4.6 
E-HR3 CAZ, CIP, CEX, AMX, ATM 3 6.6, 5, 4.6 
E-HR4 AMX, CEX, CTX, MEM, IMP, AMK 3 7.6,6.6,5 
E-HR5 CAZ, CIP, CEX, AMX, ATM 2 6, 4.6 
E-HR6 AMX, CEX, CIP, MEM, 2 6, 4.6 
E-HR7 AMX, CEX, CTX, ATM, TZP, CAZ, CIP, MEM, IMP, AMK 1 1.8 
E-HR8 CAZ, CIP, CEX, AMX, ATM 1 4.6 
E-HR9 AMX, CEX, CIP, MEM, 1 4.6 
E-HR10 AMX, CEX, CTX, MEM, IMP, AMK 2 6, 4.6 
E-HR11 AMX, CEX, CTX, MEM, IMP, AMK 2 4.6, 2 
E-HR12 CAZ, CIP, CEX, AMX, ATM 1 5.8 
E-HR13 AMX, CEX, ATM, TZP, CAZ, CIP, IMP 3 7.6, 6.6, 5 
E-HR14 AMX, CEX, CIP, ATM, MEM, TZP, CAZ 1 5.8 
E-HR15 AMX, CEX, CIP, MEM 2 4.6, 2 
E-HR16 AMX, CEX, ATM, TZP, CAZ, CIP, IMP 3 6.6, 5, 4.6 
E-HR17 AMX, CEX, ATM, TZP, CAZ, CIP, IMP 3 6.6, 5, 4.6 
E-HR18 AMX, CEX, CTX, MEM, IMP, AMK 2 4.6, 2 
E-HR19 AMX, CEX, CTX, ATM, TZP, CAZ, CIP, MEM, IMP, AMK 1 1.8 
E-HR20 AMX, CEX, CIP, MEM 3 7.6, 6.6, 5 
E-HR21 AMX, CEX, CTX, ATM, TZP, CAZ, CIP, MEM, IMP, AMK 4 
7.3, 4.6, 3.4, 
1.8 
E-HR22 AMX, CEX, CIP, ATM, MEM, TZP, CAZ 3 7.2, 5, 3.2 
E-HR23 AMX, CEX, CTX, MEM, IMP, AMK 3 7.2, 5, 3.2 
E-HR24 AMX, CEX, CIP, ATM, MEM, TZP, CAZ 3 7.2, 5, 3.2 
E-HR25 AMX, CEX, CTX, MEM, IMP, AMK 3 7.2, 6.6, 5 
E-HR26 AMX, CEX, CTX, ATM, TZP, CAZ, CIP, MEM, IMP, AMK 1 1.8 
 
Amoxicillin- AMX; Tazobactam 10/ 
Piperacillin 75-TZP; Ceftazidime (30 μg)-CAZ; 
Imipenem (10 μg)-IPM; Cefotaxime (30 μg)-CTX; 
Aztreonam (30 μg)-ATM; Cefalexin (30 μg)-CEX; 
Ciprofloxacin-CIP; meropenem-MEM; Amikacin 
(30 μg)-AMK. 
 Plasmid containing non-O157 VTEC 
isolates suggests that the resistance could be 
chromosomal, or plasmid-mediated. Plasmid curing 
tests were performed to decide if the drug resistance 
was plasmid-mediated. The study has revealed that 
isolates became sensitive to ampicillin after plasmid 
curing and suggested that antibiotic resistance could 
be plasmid-mediated. Different groups of antibiotics 
(penicillin, fluoroquinolones, aminoglycoside, 
cephalosporins, carbapenem, and monobactams) 
were selected for antibiotic susceptibility.  Among 
the 26 isolates of non-O157 VTEC,  8 isolates (E-
HR3, E-HR5, E-HR7, E-HR10, E-HR14, E-HR19, 
E-HR21, and E-HR 26) have changed their 
susceptibility patterns against the tested penicillin 
group of antibiotic while the rest 14 isolates remain 
unchanged after curing the plasmid. For the 
penicillin, three isolates (E-HR7, E-HR19, and E-
HR26) were cured and became sensitive to the 
amoxicillin but not to cefalexin, ciprofloxacin, 
imipenem, and aztreonam while sensitive to 
amikacin. For the other isolates; E-HR3, E-HR5, E-
HR10, E-HR14 and E-HR21 remained resistant to 
amoxicillin but exhibited wider zone of inhibition 
after plasmid curing. However, all the 8 isolates 
showed different antimicrobial patterns to amikacin, 
cefalexin, ciprofloxacin, imipenem, and aztreonam 
post-curing assay. Three isolates, (E-HR3, E-HR5, 
E-HR7) were resistant to fluoroquinolones 
(Ciprofloxacin) after curing of plasmids while 
initially those isolates were sensitive. Although 
susceptibility patterns have varied widely and 
susceptibility patterns were not the same in all 
isolates, i.e. resistance to certain antibiotics was the 
same and only few were different. Therefore, this 
study revealed the loss of resistant properties in 
cured non-O157 VTEC against amoxicillin (25 
mg/mL) as well as to multiple antibiotics (Table 3). 
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a) 
Table 3.  Antibiotic susceptibility patterns of plasmid positive non-O157 VTEC isolates by zones of 
inhibition (nearest whole millimetre) before and after plasmid curing experiments. 
Non-
O157 
VTEC 
Antibiotics  
Amoxicillin Cefalexin Ciprofloxacin Amikacin Imipenem Aztreonam 
B A SP B A SP B A SP B A SP B A SP B A SP 
E-HR 3 9 11 R 4 7 R 18 11** R 5 2 R 4 6 R 8 10 R 
E-HR5 7 9 R 4 6 R 19 12** R 6 22^ S 4 4 R 16 10** R 
E-HR7 4 18* S 3 3 R 16 8** R 14 17 S 5 7 R 11 6** R 
E-HR10 7 11 R 4 8 R 4 10^ R 6 8 R 4 8 R 8 8 R 
E-HR14 5 8 R 5 7 R 7 10^ R 11 15 S 2 2 R 15 9** R 
E-HR19 5 18* S 8 4 R 6 6 R 15 17 S 2 2 R 8 10^ R 
E-HR21 7 9 R 7 4 R 8 4** R 15 19 S 10 10 R  8 10^ R 
E-HR26 4 17* S 2 2 R 6 2** R 15 18 S 3 5 R 8 8 R 
B: Before; A: After; *Cured; ^ More sensitive; ** More resistant; R: Resistant; S: Sensitive; SP: 
Susceptibility patterns. 
 
Based on gel electrophoresis after post-
curing of plasmid, the plasmid copies remained the 
same in 5 isolates (E-HR3, E-HR5, E-HR10, E-
HR14, E-HR21) while 3 isolates (E-HR7, E-HR19, 
and E-HR26) did not harbour any plasmid copies. 
Plasmid bands were not spotted after the 
electrophoretic separation of crude (mutant) DNA 
extracts from three amoxicillin-susceptible mutants. 
Therefore, this study confirmed that ethidium 
bromide was able to eliminate all the plasmid bands 
and resistance properties of the non-O157 VT gene 
are plasmid mediated (Fig. 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Plasmid curing process of a) pre curing and b) post curing among the non-O157 VTEC; M: 
DNA ladder, Lanes: from 1-8 represent amplified product. Lane 1: E-HR3; Lane 2: E-HR5; Lane 3: 
E-HR7; Lane 4: E-HR10; Lane 5: E-HR14; Lane 6: E-HR19; Lane 7: E-HR21; Lane 8: E-HR26. 
 
In terms of the post plasmid curing 
phylogenetic relatedness, the dendrogram of 
clustering by UPGMA algorithm based on 
similarity coefficient showed the consistent 
distribution in some cases. The distribution was 
consistent among the antimicrobial susceptibility 
patterns and several plasmid bands of non-O157 
VTEC isolates.  Among the 8 isolates, 3 strains (E-
HR7, E-HR19, and E-HR26) harboured 1 plasmid 
band in clade 1 while in clade 2, each isolate (E-
HR3, E-HR5, and E-HR10) harboured 3, 2 and 2 
plasmids respectively. Three isolates (E-HR7, E-
HR19 and E-HR 26) exhibited similarity based on 
plasmid analysis and antimicrobial susceptibility 
patterns. E-HR14 isolates have no phylogenetic 
relationship with other groups of plasmids 
containing non-O157 VTEC isolates (Fig.5). 
b) 
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Figure 5. Phylogenetic relatedness. 
 
 Of the total 26 plasmids containing non-
O157 VTEC isolates, 8 isolates (E-HR3, E-HR5, E-
HR7, E-HR10, E-HR14, E-HR19, E-HR21, and E-
HR26 showed variation in susceptibility patterns 
aligned with different plasmid size and bands 
significantly. This observation was considered 
encouraging as it suggests that the presence of VT 
gene could be plasmid-mediated. In this study, 
purified plasmid was used as DNA template for 
polymerase chain reaction (PCR). Based on gel 
electrophoresis, 3 isolates (E-HR7, E-HR19, and E-
HR26) were VT positive. VT1 and VT2 genes 
amplified with 348bp and 584bp, respectively. The 
remaining 5 isolates were VT negative (Fig. 6). 
 
 
Figure 6. Plasmid-mediated non-O157 VTEC. 
M: DNA ladder, Lanes: from 1-9 represent 
amplified product (348 bp and 584 bp). Lane 1: 
positive control; Lane 2:E-HR3; Lane 3:E-HR5; 
Lane 4:E-HR7; Lane 5:E-HR10; Lane 6:E-
HR14; Lane 7:E-HR19; Lane 8:E-HR21; Lane 
9:E-HR26. 
 
Discussion: 
Pathogenic isolates of non-O157 VTEC 
have a comparatively high potential for developing 
resistance. Besides, resistance genes can be 
associated with mobile DNA plasmids which 
facilitate genetic materials to the same species and 
as well as to bacteria in another genus or species 
(21). Indeed, the flow of genetic materials between 
and within the genomes in bacteria is extensive and 
well established (22).  
 This study has revealed that three isolates 
(E-HR7, E-HR19, and E-HR26) were sensitive to 
penicillin while resistance to other antibiotic but 
remain sensitive to amikacin (aminoglycoside). A 
possible contributory factor such as plasmid curing 
is a chemical treatment in cells. The effectiveness of 
the curing agents varies, and the variation depends 
on the curing agent and microorganism being cured. 
Ethidium bromide was used according to Zaman et 
al., (18) which is also supported by El-Deep et al., 
(23) for plasmid curing among E. coli isolates.  
 Variation in the plasmid profile among the 
investigated isolates of non-O157 VTEC proposes 
their diversity. Recent studies of Dadi et al., (24) 
and Ineta et al., (15) have shown agreement with 
these findings where a wide range of distinct 
plasmid profiles was found among the tested 
organisms. In this study, all the clinical isolates of 
non-O157 VTEC possessed molecular size ranging 
from 1.8kb to 7.6kb. Besides, all the plasmids 
containing isolates that are multidrug resistance, can 
cause disease with hard treatment. In this context, 
Gomes et al., have reported that the large virulence 
plasmid in non-O157 VTEC causes numerous 
diseases (25). In addition, various microorganisms 
are continuously exposed to hospital environment, 
and their resistance increases as a function of time 
due to exposure to many factors. Moreover, bacteria 
acquire resistance through natural or intrinsic 
resistance. Multiple mechanisms of antibiotic are 
responsible for resistance such as multidrug efflux, 
drug inactivation, drug target alteration, reduction 
of permeability or uptake, extrachromosomal or 
acquired resistance (7, 26, 27). These contributory 
factors rise the global dissemination of MDR 
bacteria. The fast dissemination of antibiotic 
resistances demands effective means to stop or slow 
down. Thus, the studies confirmed the important 
role of plasmids number and size on resistance 
characteristics in non-O157 VTEC. 
 Plasmid curing was confirmed by agarose 
gel electrophoresis and showed that the, cells 
treated with ethidium bromide, are able to exclude 
all the plasmid bands in some isolates. Among the 
curing agents, ethidium bromide was more effective 
compared to others such as sodium dodecyl sulfate, 
and acridine orange (18). In this study, treatment 
with ethidium bromide followed by sub-lethal 
concentration of antibiotic; penicillin (amoxicillin) 
selection resulted in the more effective curing 
process. The plasmid curing process is rapid, simple 
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and sufficient for a wide range of E. coli and other 
bacterial species (15, 18, 28) but yet to observe 
agents to eliminate all plasmids from different host 
(29). The Plasmids loss in cured strains resulted in 
the vanishing of the outer membrane components as 
well as changes in the thickness peptidoglycan 
layer. In case of large plasmid, it can be correlated 
with the loss of amoxicillin resistance. Generally, 
curing efficacy can be confirmed by the physical 
loss of plasmid (30).  However, the effectiveness of 
curing methods depends on the nature of the 
bacterial host and plasmids, where some may work 
better than the others or some may not. Plasmid 
interference for curing antibiotic resistant therapy 
other than ethidium bromide could be a possible 
simple oral administrative route against the threat of 
multidrug-resistant. 
 A further variation was observed in plasmid 
analysis, and antimicrobial susceptibility, and 
similarity coefficients by phylogenetic grouping 
after the post plasmid curing isolates. Additional 
factors might be contributory reasons for different 
plasmid size and bands. Plasmid producing 
multidrug-resistant non-O157 VTEC isolates 
exhibits high molecular weights and higher resistant 
to antibiotics. Also, some of the isolates after 
plasmid curing continued to be resistant to multiple 
antibiotics. These could be due to the presence of 
multiple resistant genes in bacteria, which could be 
transferred to not only through the same species but 
also to others. So, the presence of multiple bands 
with varying size in DNA plasmid has been 
characterized in terms of their antimicrobial 
resistance (15).   
 Currently, extended-spectrum β-lactamases 
(ESBL), AmpC β-lactamase (pAmpC) blaCMY−2, 
carbapenemases blaNDM−1, blaOXA−48, and blaKPC−2 
described as plasmid-mediated resistance 
mechanisms are increasing in E. coli (31-32). This 
study reveals that the emergence of plasmid-
mediated verotoxin gene (PMVT) resistance can 
also be developed through horizontal gene transfer 
and can co-exist on the same plasmid and may able 
to transfer to recipients. The association between 
the resistant phenotypes and plasmid replicons has 
been tested while accounting for phylogenetic 
similarity for each trait. Besides, PCR assay 
confirmed that VT1 and VT2 genes were amplified 
at 348bp and 584bp respectively, and the bacterial 
genome sequence analysis aligned with VT1 and 
VT2 genes. Analysis of bacterial genome sequences 
and horizontally transferred plasmids highlighted 
the presence of plasmid-mediated VT gene in non-
O157 E. coli isolates.  
 
 
Conclusion: 
 The existence, and prevalence of bacterial 
antibiotic resistance are continuing, and critically ill 
patients at the hospital are at high risk of being 
infected. This study highlights that the clinical 
isolates resistant to multiple antibiotics aligned with 
different plasmid number and size could be a 
possible carrier for VT gene. More importantly, VT 
gene is closely related to various antibiotics 
belonging to the transmissible plasmids. As a 
whole, this study confirms the presence of VT gene 
in clinical isolates of non-O157 E. coli which might 
complicate the antimicrobial resistance scenario 
throughout the world. The findings of this study 
provide an additional knowledge to the global 
literature on plasmid-mediated VT gene in non-
O157 E. coli. It can be recommended that more 
attention should be paid to the surveillance of 
plasmid-mediated VT gene. To the best of our 
knowledge, this is the first report in the global 
literature on plasmid-mediated VT gene in non-
O157 E. coli. Therefore, a systematic screening 
policy should be implemented for rapid detection of 
the plasmid-mediated multidrug-resistant isolates to 
prevent the horizontal gene transfer associated with 
effective curing to avoid dissemination of VT gene 
in the future. 
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بوساطة البلازميد المعزولة من الرضع والأطفال  751Oالتوصيف الجزيئي لبكتريا الإشريكية القولونية بخلايا 
 المصابين بالإسهال
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 :الخلاصة
من المشاكل الصحية الخطيرة ، وهذا  )CETV( العدوى المسببة للسموم القولونية كبيرة في حدوث العدوى غيرالزيادة الأصبحت 
العالم. تهدف هذه الدراسة إلى التحقق الوضع يزداد سوًءا بسبب انتشار الكائنات الحية الدقيقة المقاومة للبلازما متعددة الأدوية في جميع أنحاء 
 731القولونية. حددت التقنيات الميكروبيولوجية القياسية ما مجموعه  .E 751.E بوساطة البلازميد في غير nixotorev من وجود الجين
لفحص انتشار  خضعت هذه العزلات .iniM dimsalP perptcefreP تم الكشف عن البلازميد من خلال مجموعة إعداد .iloc .E عزلة
 )RCP( القرص ومعالجة البلازميد بمعالجة بروميد إيثيديوم. تم إخضاع العزلات المحتوية على البلازميد إلى تفاعل سلسلة بوليميراز
،  731 iloc .E من بين عزلات .iloc .E 751.E في غير )2TV و 1TV( روتوكسين بوساطة البلازميدrev للتحقيق في وجود جين ال
 عزلة غير 62و  751O ٪) من فيروتوكسين تنتج أنماط مصلية غير1.95( 92بينما كانت عزلات  iloc .E 751O زلة غيرع 94كانت 
تمتلك بلازميدات. بعض العزلات تحتوي على بلازميد أحادي الحجم في حين أن البعض الآخر يحتوي على بلازميدات  CETV 751O
٪) مقاوم للعديد من 001كيلوبايت. كان البلازميد الذي يحتوي على جميع العزلات ( 6.7ت إلى كيلوباي 8.1متعددة بأحجام مختلفة تتراوح من 
عزلات الأدوية. تغيرت ثماني عزلات في أنماط قابليتها للحساسية بينما وجد أن ثلاث عزلات تفقد البلازميد بعد المعالجة بالبلازميد وبقيت ال
أوضحت  .iloc .E 751O سموم فيروتينية بوساطة البلازميد تنتج غير القولونية 3لمختلفة بـ ا RCP ) ثابتة. تتميز مجموعات51المتبقية (
على حد علمنا ، هذا هو التقرير الأول في الأدبيات و .iloc .E 751O بوساطة البلازميد في غير nixotorev الدراسة الحالية حدوث الجين
يجب أن يعطي التشخيص والمراقبة في الوقت المناسب  .iloc .E 751.E غير بوساطة البلازميد في nixotorev العالمية حول الجين
 .الجين بوساطة البلازميد بين نفس البكتيريا أو الأنواع الأخرى انتقالالأولوية لوقف أو إبطاء الجين للنشر عن طريق  CETV للعدوى
 
 .الفيروكسين، البلازميد،  iloc .E 751O ، غير القولونية، ماليزياالإسهال الكلمات المفتاحية:
 
